Creative Cafes, Inc. since Jan 1990
Controller
Stix Restaurant 1995 - 1998
Controller
Education:
Baldwin-Wallace College 1987 - 1989
Bachelor of Arts (B.A.), Arts, Entertainment, and Media Management
Cuyahoga Community College 1983 - 1986
Associate of Arts (A.A.), Accounting and Finance
Skills:
Accounts Payable Financial Reporting Forecasting Cash Flow Payroll General Ledger Quickbooks Accounting Budgets Microsoft Excel Financial Analysis Microsoft Office Microsoft Word Wine Lists Human Resources Personal Finance
Cleveland Housing Network
Project Manager - Real Estate Development
City of Cleveland Jun 2013 - Apr 2015
Deputy Manager, Housing Development Office
City of Cleveland Sep 2009 - May 2013
Project Manager
Miyares and Harrington Llp Sep 2006 - Dec 2008
Associate
U.s. Department of Justice Sep 2005 - Dec 2005
Law Clerk
Education:
Cleveland State University 2011 - 2012
Boston College 2003 - 2006
Doctor of Jurisprudence, Doctorates, Law
Kenyon College 1996 - 2000
Bachelors, Bachelor of Arts, Philosophy
Skills:
Real Estate Transactions Community Development Land Use Zoning Contract Negotiation Negotiation Public Administration Litigation Real Estate Public Relations Environmental Law Real Estate Development Economic Development Civil Litigation Public Policy Public Speaking Community Outreach Research Leadership Project Planning Project Management Organizational Leadership
Dr. Downing graduated from the Indiana University School of Medicine in 1989. He works in Kokomo, IN and specializes in Pulmonary Disease. Dr. Downing is affiliated with Community Howard Regional Health and Saint Vincent Kokomo.
in all, spent a little time at an airport gate before takeoff. The children were able to interact with more than a dozen therapy dogs brought in just for the event. Then, around 7 p.m., those gathered -- which included St. Jude President Dr. James Downing -- boarded the 757 airplane for the "flight."
Date: Dec 21, 2016
Category: Business
Source: Google
Certain Genes Do Increase Risk of Chilhood Cancers
The study led by the CEO and president of the hospital Dr. James Downing is part of the Pediatric Genome Project, which both teams have been working on. Considered as the "most ambitious effort," it seeks to determine the beginnings of childhood cancers to be able to find the precise medicine. It lo
These findings "give us fundamental insights into the etiology of pediatric cancerto help treat patients," says James Downing, chair of Childhood Cancer Treatment, president and CEO of St. Jude Children's Research Hospital and co-author of the new study, which is part of the Saint JudeWashington U
Date: Nov 18, 2015
Category: Health
Source: Google
More Than 8 Percent of Kids With Cancer May Be Genetically Prone to the Disease
"This paper marks an important turning point in our understanding of pediatric cancer risk and will likely change how patients are evaluated," corresponding author Dr. James Downing, St. Jude president and chief executive officer, said in a news release from the Memphis hospital.
Also speaking at the ceremony was Lt. Col. Steven Clark, commander of WVU Army ROTC, who brought the audiences attention to retired Navy Lt. James Downing, who was present at the attacks on Pearl Harbor.
Date: Dec 07, 2014
Category: U.S.
Source: Google
Hillary Clinton Visits St. Jude Hospital, Helps Open $200 Million Center
The Marlo Thomas Center for Global Education and Collaboration will also host a college graduate and post-doctoral fellow program; St. Jude will become a degree-granting institution, added St. Jude CEO Dr. James Downing.
Date: Nov 24, 2014
Category: Health
Source: Google
DNA sequencing project could lead to treatments for deadly childhood cancers
Early on, target gene sequencing only looked at the part of the genome of interestWe knew in pediatric tumors, there are a large number of structural alterations, and [less comprehensive] approaches could not detect those abnormalities, Dr. James Downing, the St. Jude scientific director who lea
Date: May 30, 2012
Category: Health
Source: Google
Decoding Cancer: Scientists Release 520 Tumor Genomes from Pediatric Patients
f we only sequenced the tumor, and not normal non-tumor DNA from the patient, we would end up with thousands to hundreds of thousands of potential mutations, and no way to sort through which ones were important to cancer, says Dr. James Downing, scientific director and leader of the PCGP at St. Jud